Business / Finance

RSS

Kewaunee Scientific's sales up 2% in first quarter 2015

Kewaunee Scientific Corporation today reported results for its first quarter ended July 31, 2015.

26 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

MNX Global Logistics' new Life Sciences Logistics Centre opens in Amsterdam

MNX Global Logistics announces the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol. This facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for our Life Sciences and Medical Device customers throughout Europe.

25 Aug 2015

Inovalon signs definitive agreement to acquire Avalere Health

Inovalon, a leading technology company providing advanced, cloud-based data analytics and data-driven intervention platforms to the healthcare industry, has entered into a definitive agreement to acquire Avalere Health, Inc., a leading provider of data-driven advisory services and business intelligence solutions to the pharmaceutical and life sciences industry.

25 Aug 2015

Ascendis Pharma's total revenue decreases 50% to €1.9 million in second quarter 2015

Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced financial results for the three and six months ended June 30, 2015.

25 Aug 2015

CRH acquires assets of Physicians Immediate Med

CRH Healthcare, a quality- and patient-focused operator of urgent care centers in Alabama and Georgia recently acquired the assets of Physicians Immediate Med, the leading urgent care and family care platform in Atlanta.

25 Aug 2015

ulrich medical USA plans to increase workforce to meet the growing demands of spine implant business

ulrich medical USA, Inc. today announced plans to significantly increase its U.S. workforce in order to accommodate for the increasing demands of its dynamic spine implant business. Fueled by four consecutive years of profitable, double-digit growth and twenty percent year-to-date growth, the company is investing in its future and expanding across multiple functional areas within North America.

25 Aug 2015

Accutest makes strategic expansion into Latin America to support the growth of pharmaceutical sector

Accutest Research Laboratories, a leading global Contract Research Organization (CRO), further pursues its strategic expansion into Latin America by opening offices and establishing operational presence in Brazil.

25 Aug 2015

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma Limited, a clinical-stage biotechnology company, is pleased to announce the closing of its U.S. initial public offering of 1,500,000 American Depositary Shares (ADSs), representing 30,000,000 fully paid ordinary shares of Benitec, together with warrants to purchase 500,000 ADSs, representing 10,000,000 fully paid ordinary shares.

24 Aug 2015

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.

24 Aug 2015

UPMC WorkPartners receives A-rating from A.M. Best

UPMC WorkPartners has retained its financial strength rating of A- (Excellent) from A.M. Best, the world's oldest and most authoritative insurance rating and information source.

24 Aug 2015

DST Systems completes acquisition of Wealth Management Systems

DST Systems, Inc., a global provider of strategically unified data management, business processing, and customer communication solutions, today announced it has completed the previously announced acquisition of retirement plan rollover specialist Wealth Management Systems Inc.

23 Aug 2015

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.

20 Aug 2015

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company Specialised Therapeutics Australia Pty (STA) to market and distribute the drug candidate APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

DelMar closes on $2.6 million registered direct placement

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the closing of a registered direct placement (Placement) with $2.6 million received from the offering.

20 Aug 2015

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreement with European pharmaceutical partner company PharmaMar to market and distribute the novel oncology drug APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

Cyberonics, Sorin provide update on pending business combination

Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination (the "Transaction").

20 Aug 2015

Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Cyberonics, Inc. today announced results for the quarter ended July 24, 2015.

20 Aug 2015

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout, on a debt-free basis, for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.

20 Aug 2015

Equashield reports record revenue growth, expands production facilities for future growth

Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.

19 Aug 2015

Business / Finance

Kewaunee Scientific's sales up 2% in first quarter 2015

Shire enters into agreement with Sanquin for CINRYZE

MNX Global Logistics' new Life Sciences Logistics Centre opens in Amsterdam

Inovalon signs definitive agreement to acquire Avalere Health

Ascendis Pharma's total revenue decreases 50% to €1.9 million in second quarter 2015

CRH acquires assets of Physicians Immediate Med

ulrich medical USA plans to increase workforce to meet the growing demands of spine implant business

Accutest makes strategic expansion into Latin America to support the growth of pharmaceutical sector

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

UPMC WorkPartners receives A-rating from A.M. Best

DST Systems completes acquisition of Wealth Management Systems

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

DelMar closes on $2.6 million registered direct placement

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

Cyberonics, Sorin provide update on pending business combination

Cyberonics reports record worldwide net sales of $81.0 million for first fiscal quarter 2016

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Equashield reports record revenue growth, expands production facilities for future growth

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News